In this study, we aim to assess BC proliferative fraction using Ki67 assessment utilising matched cases prepared as TMA and WTS taking into account the optimal cut-off value for Ki67 assessed on TMA, the common method of proliferation assessment in the research setting on large cohorts. This evidence concerns the gene MKI67 and breast cancer.